Author:
Schneider M. R.,Schiller C. -D.,Humm A.,von Angerer E.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference11 articles.
1. von Angerer E, Prekajac J, Berger MR (1985) The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors. Eur J Cancer Clin Oncol 21:531–537
2. Bartke A, Mason M, Dalterio S, Bex F (1978) Effects of tamoxifen on plasma concentrations of testosterone and gonadotrophins in male rat. J Endocrinol 79:239–240
3. Griffiths K, Peeling WB, Harper ME, Davies P, Pierrepoint CG (1981) Prostatic cancer: rational for hormonal therapy. In: Stoll BA (ed) Hormonal management of endocrine-related cancer. Lloyd-Luke, London, pp 131–147
4. Ip MM, Milholland RJ, Rosen F (1980) Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma. Cancer Res 40:2188–2193
5. Leinonen P, Bolton NJ, Kontturi M, Vikko R (1982) Rapid endocrine effects of tamoxifen and testolactone in prostatic carcinoma patients. Prostate 3:589–597
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献